These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35644025)

  • 1. In silico analyses of acetylcholinesterase (AChE) and its genetic variants in interaction with the anti-Alzheimer drug Rivastigmine.
    Pereira GRC; Gonçalves LM; Abrahim-Vieira BA; De Mesquita JF
    J Cell Biochem; 2022 Jul; 123(7):1259-1277. PubMed ID: 35644025
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chintha N; Jupudi S; Palathoti N; Bharathi J J; Justin A
    J Biomol Struct Dyn; 2023; 41(22):12620-12631. PubMed ID: 36644856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study.
    Saravanaraman P; Chinnadurai RK; Boopathy R
    J Comput Biol; 2014 Aug; 21(8):632-47. PubMed ID: 24611490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
    Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
    Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
    Ghosh S; Jana K; Ganguly B
    Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
    Azmal M; Hossen MS; Shohan MNH; Taqui R; Malik A; Ghosh A
    PLoS One; 2024; 19(6):e0304490. PubMed ID: 38833492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential acetylcholinesterase inhibitors: molecular docking, molecular dynamics, and in silico prediction.
    Kiametis AS; Silva MA; Romeiro LA; Martins JB; Gargano R
    J Mol Model; 2017 Feb; 23(2):67. PubMed ID: 28185116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations.
    Honorio P; Sainimnuan S; Hannongbua S; Saparpakorn P
    Chem Biol Interact; 2021 Aug; 344():109523. PubMed ID: 34033838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
    Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
    J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding interactions and in silico ADME prediction of isoconessimine derivatives as potent acetylcholinesterase inhibitors.
    Tue-Ngeun P; Rakitikul W; Thinkumrob N; Hannongbua S; Meelua W; Jitonnom J
    J Mol Graph Model; 2024 Jun; 129():108746. PubMed ID: 38401250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
    Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
    Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
    Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies.
    Ali MR; Sadoqi M; Møller SG; Boutajangout A; Mezei M
    J Mol Graph Model; 2017 Sep; 76():36-42. PubMed ID: 28711758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment.
    Chitra L; Kumar CR; Basha HM; Ponne S; Boopathy R
    Proteins; 2013 Jul; 81(7):1179-91. PubMed ID: 23408593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
    Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
    Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.